| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Sunshine Biopharma, Inc | Chief Executive Officer, Director, 10%+ Owner | Series B Preferred Stock | 130,000 | $13,000 | $0.1000 | 04 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SBFM | Sunshine Biopharma, Inc | 04 Mar 2024 | 1 | +$10,000 | 4 | Chief Executive Officer, Director, 10%+ Owner | 05 Mar 2024, 16:05 |
| SBFM | Sunshine Biopharma, Inc | 08 Feb 2024 | 1 | +$2,000 | 4 | Chief Executive Officer, Director, 10%+ Owner | 12 Feb 2024, 16:05 |
| SBFM | Sunshine Biopharma, Inc | 18 Feb 2022 | 1 | -$99,000 | 4 | Chief Executive Officer, Director | 22 Feb 2022, 12:07 |